Consequences of AhR activation in steady-state dendritic cells.
about
IDO2 in Immunomodulation and Autoimmune DiseaseAutoimmunity and infection in Sjögren's syndromeToward understanding the role of aryl hydrocarbon receptor in the immune system: current progress and future trendsNew insights into the role of the aryl hydrocarbon receptor in the function of CD11c⁺ cells during respiratory viral infectionRole and therapeutic value of dendritic cells in central nervous system autoimmunity.Linking the aryl hydrocarbon receptor with altered DNA methylation patterns and developmentally induced aberrant antiviral CD8+ T cell responses.Dietary ligands of the aryl hydrocarbon receptor induce anti-inflammatory and immunoregulatory effects on murine dendritic cells.The Aryl Hydrocarbon Receptor Influences Transplant Outcomes in Response to Environmental Signals.3,3'-Diindolylmethane Inhibits Flt3L/GM-CSF-induced-bone Marrow-derived CD103(+) Dendritic Cell Differentiation Regulating Phosphorylation of STAT3 and STAT5.Dendritic cells provide a potential link between smoking and inflammation in rheumatoid arthritis.Indoleamine 2,3-dioxygenase and dendritic cell tolerogenicity.Regulation of central nervous system autoimmunity by the aryl hydrocarbon receptor.Cytokines as molecular targets for aryl hydrocarbon receptor ligands: implications for toxicity and xenobiotic detoxification.The aryl hydrocarbon receptor and food allergy.Mode of action and dose-response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study.Mechanisms of chemical cooperative carcinogenesis by epidermal Langerhans cells.Ablating the aryl hydrocarbon receptor (AhR) in CD11c+ cells perturbs intestinal epithelium development and intestinal immunity.Interrelated Roles for the Aryl Hydrocarbon Receptor and Hypoxia Inducible Factor-1α in the Immune Response to Infection.Discovery of IDO1 Inhibitors: From Bench to Bedside.Indoleamine 2,3-Dioxygenase and Its Therapeutic Inhibition in Cancer.Aryl Hydrocarbon Receptor Ligands Indoxyl 3-sulfate and Indole-3-carbinol Inhibit FMS-like Tyrosine Kinase 3 Ligand-induced Bone Marrow-derived plasmacytoid Dendritic Cell Differentiation
P2860
Q27006786-7120AEB8-62A0-4968-8883-7A4600DEF5D6Q27026174-CE38C3A6-D076-426E-8390-89FC2B514557Q27026898-C517EB48-EB65-43CA-B618-B09356988647Q33723198-C9CF5C8E-D57D-4808-B284-C4C35DA4E72AQ34924088-2C564DE6-F700-49BF-8DCD-6CC0679E997BQ35472487-199547C4-2D6A-440F-B215-5D93ED370834Q35551015-E29C3606-97A2-4E3E-9CB1-D277E39A0D0CQ36243084-DBFAB388-A1EE-4860-BD19-216CD415072FQ36427732-1FEBC29F-E621-472D-A0D6-58369B87CBBBQ36633164-44EDB847-EEBA-48BB-ABB6-2DEE9C2C508DQ36821053-BBF09B94-A701-44F8-BBC1-742A9AD7B6BAQ37284511-1B328664-D743-49A8-9CBD-7CDAEC4DEF1AQ38066512-C80C2A62-50B0-4744-B27D-4AE44E76BC8AQ38112753-0A2EE43C-9517-4E32-8340-92F06F0E60F5Q38163594-773CC916-CDD7-4589-A07B-99B3EEC5E797Q38955386-D00A3435-0DD8-4A4C-9FFA-70C056C14D3BQ40067670-06ACED36-6A0D-44DF-A6FD-09CB10D154BBQ47143523-0FBFA5FD-A070-42CD-8DC1-2FF68B5BE623Q47547812-7560C9E8-978B-4045-9E1B-1DEDCC671273Q50136955-8612D689-E0AA-44C4-AC07-C154AE365053Q58574477-78B74FCF-9776-42B6-BF3A-4283788AD425
P2860
Consequences of AhR activation in steady-state dendritic cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Consequences of AhR activation in steady-state dendritic cells.
@ast
Consequences of AhR activation in steady-state dendritic cells.
@en
Consequences of AhR activation in steady-state dendritic cells.
@nl
type
label
Consequences of AhR activation in steady-state dendritic cells.
@ast
Consequences of AhR activation in steady-state dendritic cells.
@en
Consequences of AhR activation in steady-state dendritic cells.
@nl
prefLabel
Consequences of AhR activation in steady-state dendritic cells.
@ast
Consequences of AhR activation in steady-state dendritic cells.
@en
Consequences of AhR activation in steady-state dendritic cells.
@nl
P2860
P356
P1476
Consequences of AhR activation in steady-state dendritic cells.
@en
P2093
David M Shepherd
Tom Simones
P2860
P304
P356
10.1093/TOXSCI/KFQ354
P577
2010-11-19T00:00:00Z